Table 1.
Demographic characteristics of patients
| Total number of patients | 28 | |
|---|---|---|
| Gender, n (%) | ||
| Male | 18 | (64.3) |
| Female | 10 | (35.7) |
| Age (years), median (range) | 58 | (22–79) |
| Caucasians, n (%) | 28 | (100) |
| Body weight (kg), median (range) | 83 | (50–118) |
| BMI (kg/m2), median (range) | 27.9 | (18–36) |
| Height (cm), median (range) | 172 | (158–195) |
| Duration of CIDP, n (%) | ||
| ≤1 year | 9 | (32.1) |
| >1 to ≤2 years | 4 | (14.3) |
| >2 to ≤10 years | 12 | (42.9) |
| >10 years | 3 | (10.7) |
| Baseline disease characteristics | ||
| INCAT score, median (25%–75% quantile) | 3.5 | (3.0–4.5) |
| Maximum grip strength (kPa), mean (SD) | 66.7 | (37.24) |
| MRC sum score, median (25%–75% quantile) | 67.0 | (61.5–72.0) |
| Serum IgG level (mg/dl), mean (SD) | 1259.5 | (377.47) |
Demographic and baseline disease characteristics of all enrolled patients are shown.
BMI, body mass index; CIDP, chronic inflammatory demyelinating polyneuropathy; INCAT, Inflammatory Neuropathy Cause and Treatment disability scale; MRC, Medical Research Council; n, number of patients; SD, standard deviation.